ProCE Banner Activity

FLIGHT: First-line Mycophenolate + Steroids vs Standard Steroid Treatment in Patients With Newly Diagnosed Immune Thrombocytopenia Purpura

Slideset Download
Conference Coverage

Results from this phase III study of mycophenolate mofetil and a short course of corticosteroids vs corticosteroids alone as first-line treatment for patients with ITP shows the combination therapy to be safe and effective, reducing the rate of treatment failure by more than one half.

Released: December 11, 2020

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

AstraZeneca

Bristol Myers Squibb

Epizyme, Inc.

GlaxoSmithKline

Incyte Corporation

Janssen Biotech

Karyopharm Therapeutics Inc.

Novartis

PharmaEssentia Corp

Seagen

Takeda Oncology